Skip to main content

Table 4 Five year relative survival of female breast cancer patients by age, tumor stage and local treatment

From: Provision of breast cancer care and survival in Germany – results from a population-based high resolution study from Saarland

Patient/tumor characteristics Treatment N RSa SE
All patients BCS 119 84.3 4.7
  BCS + radiotherapy 3285 98.5 1.5
  Mastectomy 613 87.7 2.9
  mastectomy + radiotherapy 736 78.4 3.3
  no surgery 43 40.8 6.7
  Missing 2406 84.1 1.4
T1/T2 tumors, nodal negative BCS + radiotherapy or mastectomy 2467 99.5 1.6
T1/T2 tumors, nodal negative, 15-49 years   488 96.4 1.4
T1/T2 tumors, nodal negative, 50-69 years   1391 99.7 0.9
T1/T2 tumors, nodal negative, 70+ years   588 96.7 3.1
T1/T2 tumors, nodal positive BCS + radiotherapy or mastectomy + radiotherapy 1272 90.1 2.7
T1/T2 tumors, nodal positive, 15-49 years   316 84.8 3.1
T1/T2 tumors, nodal positive, 50-69 years   697 89.5 2.0
T1/T2 tumors, nodal positive, 70+ years   259 94.8 4.9
T3/T4; nodal negative mastectomy + radiotherapy 55 88.7 12.9
T3/T4; nodal positive mastectomy + radiotherapy 256 73.6 5.1
  1. Five year RS of female BRC patients (ICD-10: C50) from Saarland estimated for the calendar period 2005–2009 by age, tumor stage and local treatment. N: number of patients contributing survival experience; RS: point estimate of 5-year relative survival; SE: standard error of RS; a) except for age group-specific survival, age standardized estimates were derived using the ICSS weights; including patients with microscopically verified tumors and available information on age and stage and the respective local treatment; patients presenting with distant metastases or DCO notified tumors were excluded.
\